Participate in a Clinical Trial

1 ALZHEIMER'S DISEASE [READ MORE] 2 PARKINSONS'S DISEASE [READ MORE]

Science

Video: Understanding CERE-110 for Alzheimer's Video: Understanding CERE-120 for Parkinson's

Quick Links: Science at Ceregene » Neurotrophic Factors » Gene Delivery Technology »

Newsroom

05-17-12: Ceregene Parkinson's Disease Study Demonstrates Long-term Neurturin Expression
and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin) »
05-09-12: Parkinson's Disease therapeutics focal point at this year's ASGCT meeting »
12-01-11: Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120
for the Treatment of Parkinson's Disease »

Developing treatments for Parkinson's
and Alzheimer's diseases using
the combined power of neurotrophic
factors and gene therapy.